Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Malignant Melanoma

  Free Subscription


10.02.2020

1 Am J Dermatopathol
5 Anticancer Res
2 Br J Dermatol
2 Cancer Res
1 Clin Cancer Res
2 J Am Acad Dermatol
1 J Cell Physiol
2 Lancet Oncol
1 Oncogene
1 Oncol Rep
1 PLoS Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. URSO C
    Melanocytic Skin Neoplasms: What Lesson From Genomic Aberrations?
    Am J Dermatopathol. 2019;41:623-629.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. BIRKE M, Schope J, Wagenpfeil S, Vogt T, et al
    Association of Vitamin D Receptor Gene Polymorphisms With Melanoma Risk: A Meta-analysis and Systematic Review.
    Anticancer Res. 2020;40:583-595.
    PubMed     Text format     Abstract available

  3. HUAYLLANI MT, Bagaria SP, Restrepo DJ, Boczar D, et al
    Wide Excisional Surgery in Invasive Melanoma Treatment: Factors Driving Non-compliance With National Guidelines.
    Anticancer Res. 2020;40:1065-1069.
    PubMed     Text format     Abstract available

  4. HUAYLLANI MT, Bagaria SP, Restrepo DJ, Boczar D, et al
    Residual Tumor on Wide Excisional Margins After Treatment of Invasive Melanoma.
    Anticancer Res. 2020;40:1059-1063.
    PubMed     Text format     Abstract available

  5. BOCZAR D, Sisti A, Restrepo DJ, Huayllani MT, et al
    National Analysis of Patients With Ulcerated Melanoma in the United States.
    Anticancer Res. 2020;40:1055-1058.
    PubMed     Text format     Abstract available

  6. CONRAD A, Reinehr M, Holzmann D, Mangana J, et al
    Progressive Disease in Sentinel-negative Melanoma Patients: Biological Differences and Importance of Sentinel Lymph Node Biopsy.
    Anticancer Res. 2020;40:891-899.
    PubMed     Text format     Abstract available


    Br J Dermatol

  7. CUST AE
    Who dies from thin melanoma?
    Br J Dermatol. 2020 Feb 3. doi: 10.1111/bjd.18871.
    PubMed     Text format    

  8. FILONI A, Lospalluti L, Zanframundo G, De Marco A, et al
    Light brown structureless areas as predictor of melanoma in situ.
    Br J Dermatol. 2020 Feb 4. doi: 10.1111/bjd.18926.
    PubMed     Text format     Abstract available


    Cancer Res

  9. HENDERSON F, Johnston HR, Badrock AP, Jones EA, et al
    Enhanced fatty acid scavenging and glycerophospholipid metabolism accompanies melanocyte neoplasia progression in zebrafish.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-2409.
    PubMed     Text format     Abstract available

  10. KIM YJ, Tsang T, Anderson GR, Posimo JM, et al
    Inhibition of BCL2 family members increases the efficacy of copper chelation in BRAFV600E-driven melanoma.
    Cancer Res. 2020 Jan 31. pii: 0008-5472.CAN-19-1784.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  11. LUCCI A, Hall C, Patel SP, Narendran B, et al
    Circulating tumor cells and early relapse in node-positive melanoma.
    Clin Cancer Res. 2020 Feb 3. pii: 1078-0432.CCR-19-2670.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  12. KUNISHIGE JH, Doan L, Brodland DG, Zitelli JA, et al
    9-mm Surgical margin required for both LM and MIS as diagnosed in real-world community practice.
    J Am Acad Dermatol. 2019;81:e117-e118.
    PubMed     Text format    

  13. VON SCHUCKMANN LA, Khosrotehrani K, Celia B Hughes M, van der Pols JC, et al
    Prognostic implications of biopsy with tumour transection for high-risk primary melanoma patients.
    J Am Acad Dermatol. 2020 Feb 4. pii: S0190-9622(20)30153.
    PubMed     Text format    


    J Cell Physiol

  14. LUO G, Xu W, Zhao Y, Jin S, et al
    RNA m(6) A methylation regulates uveal melanoma cell proliferation, migration, and invasion by targeting c-Met.
    J Cell Physiol. 2020 Feb 4. doi: 10.1002/jcp.29608.
    PubMed     Text format     Abstract available


    Lancet Oncol

  15. DUMMER R, Brase JC, Garrett J, Campbell CD, et al
    Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF(V600)-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial.
    Lancet Oncol. 2020 Jan 30. pii: S1470-2045(20)30062.
    PubMed     Text format     Abstract available

  16. KARAKOUSIS G
    Adjuvant therapy for melanoma: how to choose?
    Lancet Oncol. 2020 Jan 30. pii: S1470-2045(20)30002.
    PubMed     Text format    


    Oncogene

  17. LI Y, Zhou Y, Li B, Chen F, et al
    WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5-MDM2-p53 pathway.
    Oncogene. 2020 Jan 31. pii: 10.1038/s41388-020-1179.
    PubMed     Text format     Abstract available


    Oncol Rep

  18. KRAJEWSKI A, Gagat M, Zuryn A, Halas-Wisniewska M, et al
    Cyclin F is involved in response to cisplatin treatment in melanoma cell lines.
    Oncol Rep. 2020 Jan 14. doi: 10.3892/or.2020.7465.
    PubMed     Text format     Abstract available


    PLoS Med

  19. TABBAKH T, Volkov A, Wakefield M, Dobbinson S, et al
    Implementation of the SunSmart program and population sun protection behaviour in Melbourne, Australia: Results from cross-sectional summer surveys from 1987 to 2017.
    PLoS Med. 2019;16:e1002932.
    PubMed     Text format     Abstract available


    PLoS One

  20. HOSNY KM, Kassem MA, Foaud MM
    Classification of skin lesions using transfer learning and augmentation with Alex-net.
    PLoS One. 2019;14:e0217293.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: